• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page
Replies
1
Views
78
  • New replies moderating enabled
Replies
1K
Views
240K
Replies
4
Views
1K
Replies
17
Views
429
Replies
0
Views
39
Replies
130
Views
8K
Replies
14
Views
571
Replies
524
Views
82K